ScheBo Biotech, a global leader in the provision of unique diagnostic tests, has made some significant improvements to its Pancreatic Elastase 1 Serum Test for acute pancreatitis. The modifications are similar to those made last year to the ScheBo Pancreatic Elastase 1 Stool Test (also known as the Faecal Elastase Test), which is now generally accepted as the non-invasive ætest of choiceÆ for measuring pancreatic exocrine function.
Other News
Latest Issues
Often, better healthcare is less about pioneering breakthroughs or techniques and more about finding ways to better use existing technology to improve outcomes. And that’s what Una Health is all about: taking an innovative approach to diagnostics to challenge traditional pathways and improve patient outcomes.
We specialise in Pathology and...
UK Neqas webinar - Introduction to the Theory and Practice of Histological Staining
Online
13-14 January, 2026
RSM / Path Soc 2026 Winter Meeting
The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026
BIVDA Regulatory Affairs Seminar
Grand Hotel, Birmingham
10 - 11 February, 2026
BDIAP Molecular Pathology Study Day
10 Union Street, London, SE1 1SZ
2 March, 2026
USCAP 115th Annual Meeting
Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026